Young Scientist Award
Anastasia Orekhova – National Medical Research Center for Therapy and Preventive Medicine
| Anastasia Orekhova |
| Affiliation |
National Medical Research Center for Therapy and Preventive Medicine |
| Country |
Russia |
| Scopus ID |
57201123629 |
| Documents |
115 |
| Citations |
128 |
| h-index |
7 |
| Subject Area |
Fungal Infection |
| Event |
World Skincare Innovation Awards |
| ORCID |
0000-0001-5887-2563 |
Anastasia Orekhova is a researcher whose scholarly activities focus on fungal infections, microbial biology, and the development of innovative approaches for antifungal treatment and diagnostic applications. Her academic record reflects sustained contributions to microbiology and biomedical sciences, particularly in studies involving Aspergillus species, Candida-related investigations, and nanoparticle-assisted therapeutic strategies.[1]
Abstract
This article presents an overview of Anastasia Orekhova’s scientific profile and research achievements in fungal infection studies. Her work encompasses pathogen biology, antifungal compounds, nanoparticle delivery systems, and diagnostic methodologies relevant to microbiological research. Through peer-reviewed publications and collaborative investigations, she has contributed to the advancement of knowledge concerning medically significant fungi and related therapeutic approaches.[2]
Keywords
Fungal Infection, Microbiology, Aspergillus, Candida, Antifungal Therapy, Nanoparticles, Biomedical Research, Diagnostic Applications.
Introduction
Research involving fungal pathogens has become increasingly important due to the clinical burden associated with invasive and opportunistic infections. Anastasia Orekhova’s studies have focused on understanding fungal mechanisms and evaluating novel strategies for treatment and detection. Her multidisciplinary research integrates microbiology, molecular science, and biomedical innovation to address challenges associated with fungal diseases.[3]
Research Profile
According to publicly available academic profiles, Orekhova has been associated with research institutions in Russia and Italy and has participated in studies related to infectious diseases and microbiology. Her scholarly output includes articles indexed in international databases and contributions addressing fungal physiology, extracellular enzymes, and therapeutic technologies.[1]
Research Contributions
- Investigation of nanoparticle-based antifungal delivery systems.
- Research on Aspergillus proteases and their biological activity.
- Studies evaluating anti-Candida compounds and natural products.
- Development of methodologies relevant to plasma protein analysis and fungal diagnostics.
Publications
Selected publications include investigations on Botrytis cinerea control through nanoparticle vectors, Aspergillus-targeted antifungal formulations, extracellular fungal proteases, and anti-Candida activity assessments. These studies have appeared in journals such as Scientific Reports, Molecules, Life, Natural Product Research, and Moscow University Biological Sciences Bulletin.[2]
Research Impact
The research portfolio demonstrates measurable scholarly engagement through indexed publications, citations, and interdisciplinary collaborations. Her investigations contribute to the broader understanding of fungal pathogenesis and support the development of evidence-based therapeutic and diagnostic approaches. Such contributions are relevant to both academic research and potential clinical applications.[4]
Award Suitability
Based on her documented publication record, research productivity, and contributions to fungal infection studies, Anastasia Orekhova demonstrates characteristics commonly associated with emerging scientific leadership. Her involvement in innovative investigations and peer-reviewed scholarship aligns with the objectives of the Young Scientist Award presented through the World Skincare Innovation Awards platform.[5]
Conclusion
Anastasia Orekhova has established a research profile centered on fungal microbiology and biomedical innovation. Through studies involving antifungal agents, nanoparticle technologies, and diagnostic methodologies, she has contributed to scientific understanding within her field. Her academic activities provide a foundation for continued research and recognition within the international scientific community.
External Links
References
- De Angelis, G., Simonetti, G., Chronopoulou, L., Orekhova, A., Badiali, C., Petruccelli, V., Portoghesi, F., D’Angeli, S., Brasili, E., & Pasqua, G. (2022). A novel approach to control Botrytis cinerea fungal infections: Uptake and biological activity of antifungals encapsulated in nanoparticle-based vectors. Scientific Reports, 12, Article 7286.
https://doi.org/10.1038/s41598-022-11533-w
- Orekhova, A., Palocci, C., Chronopoulou, L., De Angelis, G., Badiali, C., Petruccelli, V., D’Angeli, S., Pasqua, G., & Simonetti, G. (2022). Poly-(lactic-co-glycolic) acid nanoparticles entrapping pterostilbene for targeting Aspergillus section Nigri. Molecules, 27(17), 5424.
https://doi.org/10.3390/molecules27175424
- Osmolovskiy, A. A., Schmidt, L., Orekhova, A. V., Komarevtsev, S. K., Kreyer, V. G., Shabunin, S. V., & Egorov, N. S. (2021). Action of extracellular proteases of Aspergillus flavus and Aspergillus ochraceus micromycetes on plasma hemostasis proteins. Life, 11(8), 782.
https://doi.org/10.3390/life11080782
- Cairone, F., Simonetti, G., Orekhova, A., Casadei, M. A., Zengin, G., & Cesa, S. (2021). Health potential of Clery strawberries: Enzymatic inhibition and anti-Candida activity evaluation. Molecules, 26(6), 1731.
https://doi.org/10.3390/molecules26061731
- De Vita, D., Messore, A., Toniolo, C., Frezza, C., Scipione, L., Bertea, C. M., Micera, M., Di Sarno, V., Madia, V. N., Pindinello, I., & Orekhova, A. (2021). Towards a new application of amaranth seed oil as an agent against Candida albicans. Natural Product Research, 35(24), 5758–5762.
https://doi.org/10.1080/14786419.2019.1696335